tiprankstipranks
Trending News
More News >
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA

ImmunoPrecise Antibodies (IPA) Revenue

Compare
281 Followers

ImmunoPrecise Antibodies Revenue

ImmunoPrecise Antibodies had a revenue of 6.15M in the quarter ending Mar 31, 2025, with 0.42%. This bring the company's revenue in the last twelve months to 24.00M, Increased -0.29%. In the fiscal year ending Jun 30, 2024, ImmunoPrecise Antibodies had annual revenue of 24.52M with 18.65% growth.
Revenue (ttm)
24.00M
Revenue Growth
-0.71%
P/S Ratio
1.22
Revenue/Employee
$340,528
Employees
72
Market Cap
$29.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
24.52M3.85M+18.65%
Jun 30, 2023
20.66M1.30M+6.72%
Jun 30, 2022
19.36M1.45M+8.11%
Jun 30, 2021
17.91M3.85M+27.42%
Jun 30, 2020
14.06M3.13M+28.66%
Jun 30, 2019
10.93M5.48M+100.80%
Jun 30, 2018
5.44M2.81M+106.85%
Jun 30, 2017
2.63M734.40K+38.73%
Jun 30, 2016
1.90M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis